266
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Improved Tear Film Stability in Patients with Dry Eye After Hyaluronic Acid and Galactoxyloglucan Use

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 1153-1159 | Published online: 28 Apr 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tomas Loureiro, Sandra Rodrigues-Barros, Ana Rita Carreira, Filipe Gouveia-Moraes, Pedro Carreira, Ana Vide Escada, Paul Campos, Ines Machado, Nuno Campos, Renato Ambrosio$suffix/text()$suffix/text(), Timothy J Archer & Dan Z Reinstein. (2023) Corneal Epithelial Thickness Changes After Topical Treatment of Dry Eye Disease in Primary Sjögren Syndrome. Clinical Ophthalmology 17, pages 993-1005.
Read now

Articles from other publishers (7)

Giulia Coco, Danilo Iannetta, Igino Febbraro, Ester Elmo & Gianluca Manni. (2022) Efficacy of Nonpreserved Sodium Hyaluronate Artificial Tears in Dry Eye Disease Patients Treated with Prostaglandin Analogs for Primary Open-Angle Glaucoma: A Prospective, Nonrandomized, Open-Label Pilot Study. Journal of Ophthalmology 2022, pages 1-8.
Crossref
José-María Sánchez-González, Concepción De-Hita-Cantalejo & María Carmen Sánchez-González. (2022) Hyaluronic Acid and Galacto-Xyloglucan Eyedrop Efficacy in Young-Adult Oral Contraceptive Users of Childbearing Age. Journal of Clinical Medicine 11:15, pages 4458.
Crossref
María Carmen Sánchez-González, Concepción De-Hita-Cantalejo, Concepción Martínez-Lara & José-María Sánchez-González. (2022) Oral isotretinoin for acne vulgaris side effects on the ocular surface: Hyaluronic acid and galacto-xyloglucan as treatment for dry eye disease signs and symptoms. Frontiers in Medicine 9.
Crossref
José-María Sánchez-González, Concepción De-Hita-Cantalejo, Concepción Martínez-Lara & María Carmen Sánchez-González. (2022) Lipid, Aqueous and Mucin Tear Film Layer Stability and Permanence within 0.15% Liposome Crosslinked Hyaluronic Acid versus 0.15% Non-Crosslinked Hyaluronic Acid Measured with a Novel Non-Invasive Ocular Surface Analyzer. Journal of Clinical Medicine 11:13, pages 3719.
Crossref
Luca Di Cello, Marco Pellegrini, Aldo Vagge, Massimiliano Borselli, Lorenzo Ferro Desideri, Vincenzo Scorcia, Carlo E. Traverso & Giuseppe Giannaccare. (2021) Advances in the Noninvasive Diagnosis of Dry Eye Disease. Applied Sciences 11:21, pages 10384.
Crossref
Gloria Huerta Ángeles & Kristina Nešporová. (2021) Hyaluronan and its derivatives for ophthalmology: Recent advances and future perspectives. Carbohydrate Polymers 259, pages 117697.
Crossref
Jennifer P. Craig, Alex Muntz, Michael T.M. Wang, Doerte Luensmann, Jacqueline Tan, Sonia Trave Huarte, Ally L. Xue, Lyndon Jones, Mark D.P. Willcox & James S. Wolffsohn. (2021) Developing evidence-based guidance for the treatment of dry eye disease with artificial tear supplements: A six-month multicentre, double-masked randomised controlled trial. The Ocular Surface 20, pages 62-69.
Crossref